Science News
from research organizations

Silent RNAs express themselves in ALS disease

Date:
December 2, 2013
Source:
Rockefeller University Press
Summary:
RNA molecules are generally thought to be “silent” when stowed in cytoplasmic granules. But a protein mutated in some ALS patients forms granules that permit translation of stored RNAs. The finding identifies a new mechanism that could contribute to the pathology of the disease.
Share:
       
FULL STORY

Mutant Fus granules (red), which are present in some cases of ALS, coincide with sites of protein production (green), indicating that the granules are active sites of RNA translation.
Credit: Yasuda et al., 2013

RNA molecules, used by cells to make proteins, are generally thought to be "silent" when stowed in cytoplasmic granules. But a protein mutated in some ALS patients forms granules that permit translation of stored RNAs, according to a study in The Journal of Cell Biology. The finding identifies a new mechanism that could contribute to the pathology of the disease.

ALS, often referred to as "Lou Gehrig's Disease," is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Although the cause of ALS is not completely understood, researchers have been increasingly focused on RNA processing as an important cause of disease symptoms.

RNAs are gregarious, clustering with other RNA molecules and proteins to form RNP (ribonucleoprotein) complexes. RNPs then can gather into larger, more complex structures within the cell called granules. There are several kinds of granules, some that are always present and others that appear under stress, and researchers have generally thought that RNAs in granules are not translated into proteins.

A team of researchers led by Stavroula Mili from the National Cancer Institute in Bethesda, Maryland, took a closer look at the functions of a protein called Fus, which is mutated in some ALS patients and causes large RNA granules to form in the patients' cells. The researchers demonstrated that Fus normally promotes the translation of RNA found in RNPs localized in cell protrusions. But abnormal versions of Fus found in ALS patients have broader effects. Cells engineered to produce mutant Fus protein harbor cytoplasmic granules that are similar to those found in the cells of ALS patients. The researchers anticipated that RNAs in the granules would be silent, but they instead discovered that the cells translated several of the RNAs into proteins.

The results suggest a new mechanism that could potentially drive ALS, in which misdirection of RNA translation, rather than RNA silencing, might contribute to disease.


Story Source:

The above post is reprinted from materials provided by Rockefeller University Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yasuda, K., et al. The RNA-binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J. Cell Biol., December 2013

Cite This Page:

Rockefeller University Press. "Silent RNAs express themselves in ALS disease." ScienceDaily. ScienceDaily, 2 December 2013. <www.sciencedaily.com/releases/2013/12/131202121048.htm>.
Rockefeller University Press. (2013, December 2). Silent RNAs express themselves in ALS disease. ScienceDaily. Retrieved July 7, 2015 from www.sciencedaily.com/releases/2013/12/131202121048.htm
Rockefeller University Press. "Silent RNAs express themselves in ALS disease." ScienceDaily. www.sciencedaily.com/releases/2013/12/131202121048.htm (accessed July 7, 2015).

Share This Page: